Low doses of steroids can inhibit joint damage when used in the early phase of rheumatoid arthritis, according to a new review of evidence. High-quality evidence supports combining the pills with standard medications in the first two years after diagnosis. “Such treatment should be made readily available to patients,” say review authors led by John Kirwan of Liverpool Women’s Hospital in England. >>> Discuss This Story
